Economic issues in heart failure in the United States

PA Heidenreich, GC Fonarow, Y Opsha… - Journal of cardiac …, 2022 - Elsevier
Lay Summary The cost of heart failure care is high owing to the cost of hospitalization and
chronic treatments. Heart failure treatments vary in their benefit and cost. The cost …

Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week

S Sukumar, JH Wasfy, JL Januzzi, J Peppercorn… - Journal of the American …, 2023 - jacc.org
Optimal medical management of heart failure (HF) improves quality of life, decreases
mortality, and decreases hospitalizations. Cost may contribute to suboptimal adherence to …

Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis

SA Akhter, A Badami, M Murray, T Kohmoto… - The Annals of thoracic …, 2015 - Elsevier
Background We investigated the incidence and causes of unplanned hospital readmissions
after continuous-flow (CF) left ventricular assist device (LVAD) implantation. We also …

Cost‐effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system

JK Schmier, KL Ong, GC Fonarow - Clinical cardiology, 2017 - Wiley Online Library
Heart failure (HF) is a leading cause of cardiovascular mortality in the United States and
presents a substantial economic burden. A recently approved implantable wireless …

Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study: randomized controlled trial of a magnetically levitated cardiac pump in …

MR Mehra, C Salerno, JC Cleveland, S Pinney… - Circulation, 2018 - Am Heart Assoc
Background: The MOMENTUM 3 trial compares the centrifugal HeartMate 3 (HM3) with the
axial HeartMate II (HMII) continuous-flow left ventricular assist system in patients with …

Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy

P Joanne, M Kitsara, SE Boitard, H Naemetalla… - Biomaterials, 2016 - Elsevier
Limited data are available on the effects of stem cells in non-ischemic dilated
cardiomyopathy (DCM). Since the diffuse nature of the disease calls for a broad distribution …

Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation

DJ Cohen, K Wang, E Magnuson, R Smith, MC Petrie… - Heart, 2022 - heart.bmj.com
Background Transcatheter edge-to-edge mitral valve repair (TMVr) improves symptoms and
survival for patients with heart failure with reduced left ventricular ejection fraction (HFrEF) …

Cost-effectiveness

L Barnsbee, AG Barnett, K Halton, S Nghiem - Mechanical circulatory and …, 2018 - Elsevier
If VADs and ECMO are to become part of routine care, they need to demonstrate that they
are cost-effective. Otherwise, the time and money they consume would be better spent …

Heart transplant and mechanical circulatory support in patients with advanced heart failure

C Sanchez-Enrique, UP Jorde… - Revista Española de …, 2017 - Elsevier
Patients with advanced heart failure have a poor prognosis and heart transplant is still the
best treatment option. However, the scarcity of donors, long waiting times, and an increasing …

Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation

A Emin, CA Rogers, NR Banner… - European Journal of …, 2016 - academic.oup.com
OBJECTIVES Advanced chronic heart failure (ACHF) is progressive with poor prognosis and
quality of life (QoL). Heart transplantation (HTx) is an effective treatment for ACHF, but is …